Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahir Karakas

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
IEEE Transactions on Medical Imaging|June 17, 2021
Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms ChallengeVictor M Campello, Polyxeni Gkontra, Cristian Izquierdo, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
The New England Journal of Medicine|September 3, 2015
Clinical Features and Outcomes of Takotsubo (Stress) CardiomyopathyChristian Templin, Jelena R Ghadri, Johanna Diekmann, et al.
Circulation|April 20, 2011
Genetic predictors of fibrin D-dimer levels in healthy adultsNicholas L Smith, Jennifer E Huffman, David P Strachan, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
IEEE Transactions on Medical Imaging|June 17, 2021
Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms ChallengeVictor M Campello, Polyxeni Gkontra, Cristian Izquierdo, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
The New England Journal of Medicine|September 3, 2015
Clinical Features and Outcomes of Takotsubo (Stress) CardiomyopathyChristian Templin, Jelena R Ghadri, Johanna Diekmann, et al.
Circulation|April 20, 2011
Genetic predictors of fibrin D-dimer levels in healthy adultsNicholas L Smith, Jennifer E Huffman, David P Strachan, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Pageof 12